Paper Details
- Home
- Paper Details
Palmoplantar Pustulosis-like Eruption Induced by Baricitinib for Treatment of Rheumatoid Arthritis.
Author: BertsiasGeorge, KoumakiDimitra, KoumakiVasiliki, LagoudakiEleni
Original Abstract of the Article :
OBJECTIVES: Baricitinib is an orally active Janus kinase (JAK) inhibitor used in the treatment of moderate to severe rheumatoid arthritis (RA). MATERIALS AND METHODS: Here, we report the case of a 56-year-old Caucasian male diagnosed with RA who developed palmoplantar pustulosis (PPP) while being t...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993915/
データ提供:米国国立医学図書館(NLM)
Baricitinib: A Potential Pitfall for Palmoplantar Pustulosis
Baricitinib, a medication used to treat rheumatoid arthritis, has emerged as a promising treatment option for a wide range of inflammatory conditions. This case report, however, highlights a potential side effect of baricitinib, a condition called palmoplantar pustulosis (PPP). PPP is a rare skin condition that causes pustules (small, pus-filled bumps) to develop on the palms of the hands and soles of the feet. The report details the case of a 56-year-old male diagnosed with rheumatoid arthritis who developed PPP while being treated with baricitinib. This case serves as a reminder that while medications can offer tremendous benefits, it is crucial to be aware of potential side effects.
A Cautionary Tale: Understanding Potential Side Effects
This case report highlights the importance of careful monitoring and communication between patients and their healthcare providers. It underscores the need for vigilance in recognizing potential side effects of medications, especially those with broader applications. The case demonstrates that baricitinib, while effective in treating rheumatoid arthritis, can also lead to PPP in some individuals.
A Reminder: Prioritizing Patient Safety
This study serves as a reminder that the journey to better health involves a delicate balance. While medications can offer tremendous benefits, it is crucial to acknowledge the potential for side effects. Open communication between patients and their healthcare providers is essential to ensure that individuals receive appropriate care and manage potential risks effectively. This report highlights the importance of weighing the benefits and risks of medication before making treatment decisions.
Dr. Camel's Conclusion
This case report is a reminder that the desert of medical knowledge is vast and complex. Even the most promising medications can have unexpected side effects. It is essential to approach medical treatment with a discerning mind, acknowledging both the potential benefits and risks. This case underscores the importance of open communication with healthcare providers and vigilant monitoring for potential side effects. Remember, the journey to better health is a collaborative one, and it requires both patients and healthcare providers to navigate the complexities of medical treatments responsibly.
Date :
- Date Completed n.d.
- Date Revised 2022-04-12
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.